Por favor, use este identificador para citar o enlazar este ítem:
https://repositorio.uca.edu.ar/handle/123456789/9889
Título : | Treatments used for obsessive-compulsive disorder : an international perspective | Autor : | Brakoulias, Vlasios Starcevic, Vladan Albert, Umberto Arumugham, Shyam Sundar Bailey, Brenda E. Belloch, Amparo Borda, Tania Dell'Osso, Liliana Elias, Jason A. Falkenstein, Martha J. Ferrao, Ygor A. Fontenelle, Leonardo F. Jelinek, Lena Kalogeraki, Leto Kay, Brian Laurito, Luana D. Lochner, Christine Maina, Giuseppe Marazziti, Donatella Martin, Andrew Matsunaga, Hisato Miguel, Eurípedes C. Morgado, Pedro Mourikis, Irakis Pasquini, Massimo Perez Rivera, Rodrigo Potluri, Sriramya Reddy, Janardhan Y. C. Riemann, Brian C. do Rosario, Maria Conceição Shavitt, Roseli G. Stein, Dan J. Viswasam, Kirupumani Wang, Zhen Fineberg, Naomi A. |
Palabras clave : | TERAPIA PSICOANALITICA; BENZODIAZEPINAS; ANTIPSICOTICOS; TRASTORNO OBSESIVO COMPULSIVO; FARMACOTERAPIA; SEROTONINA; PSICOFARMACOLOGIA; PSICOTROPICOS | Fecha de publicación : | 2019 | Editorial : | Wiley | Cita : | Brakoulias, V. Treatments used for obsessive-compulsive disorder : an international perspective [En línea]. Human Psychopharmacology: Clinical & Experimental. 2019, 34(1). doi:10.1002/hup.2686 Disponible en: https://repositorio.uca.edu.ar/handle/123456789/9889 | Resumen : | Abstract: Objective: The objective of this study was to characterise international trends in the use of psychotropic medication, psychological therapies, and novel therapies used to treat obsessive–compulsive disorder (OCD). Methods: Researchers in the field of OCD were invited to contribute summary statistics on the characteristics of their samples. Consistency of summary statistics across countries was evaluated. Results: The study surveyed 19 expert centres from 15 countries (Argentina, Australia, Brazil, China, Germany, Greece, India, Italy, Japan, Mexico, Portugal, South Africa, Spain, the United Kingdom, and the United States) providing a total sample of 7,340 participants. Fluoxetine (n = 972; 13.2%) and fluvoxamine (n = 913; 12.4%) were the most commonly used selective serotonin reuptake inhibitor medications. Risperidone (n = 428; 7.3%) and aripiprazole (n = 415; 7.1%) were the most commonly used antipsychotic agents. Neurostimulation techniques such as transcranial magnetic stimulation, deep brain stimulation, gamma knife surgery, and psychosurgery were used in less than 1% of the sample. There was significant variation in the use and accessibility of exposure and response prevention for OCD. Conclusions: The variation between countries in treatments used for OCD needs further evaluation. Exposure and response prevention is not used as frequently as guidelines suggest and appears difficult to access in most countries. Updated treatment guidelines are recommended. | URI : | https://repositorio.uca.edu.ar/handle/123456789/9889 | ISSN : | 0885-6222 (impreso) 1099-1077 (online) |
Disciplina: | PSICOLOGIA | DOI: | 10.1002/hup.2686 | Derechos: | Acceso abierto |
Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
treatments-used-obsessive-compulsive.pdf | 573,79 kB | Adobe PDF | Visualizar/Abrir |
Visualizaciones de página(s)
117
comprobado en 30-abr-2024
Descarga(s)
1.088
comprobado en 30-abr-2024
Google ScholarTM
Consultar
Altmetric
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons